Gerard Scimeca – Chairman, CASE January 14, 2020 Energy companies have long been in the crosshairs of headline-hunting politicians looking […]
Gerard Scimeca – Chairman, CASE January 14, 2020 Before he became the world’s richest man, Jeff Bezos was sailing in […]
Matthew Kandrach – President, CARE January 8, 2020 New Mexico is a testament to the economic power of horizontal drilling, […]
Gerard Scimeca – Chairman, CASE January 13, 2020 With the new decade upon us, policymakers should make a New […]
Gerard Scimeca – Chairman, CASE January 7, 2020 Addressing sky-high healthcare costs is a pressing need in our country, […]
December 23, 2019 In what could have been the policy hallmark of his first term in office, President Trump originally […]
December 20, 2019 Consumers across the country are looking to buy gifts for their loved ones this holiday season […]
CASE Op-Ed – Naples Daily News: Congress Must Pass Market-Based Approach to Address Surprise Billing
December 19, 2019 Surprise medical billing creates undue financial hardships for patients and their families at a time when all […]
December 19, 2019 Today, the Food and Drug Administration (FDA) issued a notice of proposed rulemaking to allow the importation […]
December 18, 2019 The government’s current review of the proposed merger between defense contractor Raytheon and United Technologies (UT) may not […]
.@POTUS’ IRA is driving up Part D premiums for millions of Medicare beneficiaries, yet Dems like @SenSanders continue to help tout this disastrous legislation. The Biden-Harris @WhiteHouse is misleading the public on their policy’s real impact.
Two weeks from election day, the supposedly independent @FCC is proposing price regulation of #broadband by restricting what data plans companies can offer.
By prohibiting usage-based plans, the FCC would end up increasing prices FOR EVERYONE, including low-data users!
CASE Letter Urges FDA & FTC to Scrutinize Deal Between L’Oréal and Galderma -- "Both companies are currently under investigation or facing sizable lawsuits from claims that they have used harmful chemicals in their products."
https://caseforconsumers.org/2024/10/21/case-letter-urges-fda-ftc-to-scrutinize-deal-between-loreal-and-galderma/